Merge Labs is a research lab building non-invasive, high-bandwidth brain-computer interfaces using molecules and ultrasound instead of electrodes and implants.
Merge Labs is a research lab developing high-bandwidth brain-computer interfaces that forgo conventional electrodes and brain implants. Its approach connects with neurons using molecules and transmits information through deep-reaching modalities such as ultrasound, combined with advanced artificial intelligence. The stated purpose is to restore lost abilities, support healthier brain states and expand human capability, while keeping the technology non-invasive and usable by anyone.
The company's work spans neural interfaces, ultrasound, molecular and neurochemical interfaces, non-invasive neural stimulation and recording, neuroscience and biotechnology. Its platform is described as an entirely new technology stack that avoids implantation into brain tissue in favour of modalities designed to be safe and accessible. Merge Labs has raised more than $250m, with OpenAI among its backers.
Based in the SF Bay Area, Merge Labs operates with a research-lab culture oriented towards long-term, ambitious mission work. Its stated mission is to bridge biological and artificial intelligence to maximise human ability, agency and experience, guided by first-principles science. Relevant technical domains include brain-computer interfaces, artificial intelligence and neuroscience.
